← Home
Danaher
-9.57%
Machinery & equipment / Science and technology-based products and services
📢 Press Releases
| Date | Press release |
|---|---|
| 2025-05-29 16:30:00 | Danaher Announces Diagnostic Development And Commercialization Partnership To Scale Precision Medicine Danaher has entered a partnership with astrazeneca to scale precision medicine, including developing the next generation of ai-powered diagnostics this partnership aims to create a framework for rapid diagnostics research, development and commercialization danaher, through its centers for enabling precision medicine, will provide support in all aspects of the development cycle across diagnostic modalities washington , may 29, 2025 /prnewswire/ -- danaher corporation (nyse: dhr) (’danaher’), a global science and technology innovator, announced today the launch of a partnership with astrazeneca (lse/sto/nasdaq: azn) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments. ’precision medicines are more targeted than standard therapies and thus require precision diagnostics to determine which patients are most likely to benefit,’ said julie sawyer montgomery, danaher executive vice president. |
| 2025-05-19 08:30:00 | Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration Of Dhr Positivity After Single Infusion Of Pm359, An Investigational Prime Editor For Chronic Granulomatous Disease -- first ever clinical data supporting safety and efficacy of prime editing in humans -- -- initial data from first patient dosed in phase 1/2 trial finds single dose of pm359 led to 58% dhr positivity by day 15 and 66% by day 30, well above levels believed to be potentially curative -- |
| 2025-05-07 16:15:00 | Danaher To Present At Bank Of America Securities Healthcare Conference Washington , may 7, 2025 /prnewswire/ -- danaher corporation (nyse: dhr) announced that president and chief executive officer, rainer m. blair, will be presenting at the at the bank of america securities health care conference in las vegas, nevada on thursday, may 15, 2025 at 10:00 a.m. |
| 2025-05-06 16:15:00 | Danaher Announces Quarterly Dividend Washington , may 6, 2025 /prnewswire/ -- danaher corporation (nyse: dhr) announced today that its board of directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on july 25, 2025 to holders of record on june 27, 2025. about danaher danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. |
| 2025-04-29 10:07:00 | Kytopen And Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative Crispr-mediated Cellular Engineering Workflow Kytopen and aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. high transgene expression and improved safety profile of aldveron’s nanoplasmid™ vector technology and the gentle gene-delivery of kytopen’s flowfect tx™ platform with unlimited scale, together offer enhanced crispr-mediated t-cell engineering resulting in high yields. |
| 2025-04-22 06:00:00 |
|
| 2025-03-20 16:15:00 |
|
| 2025-03-10 08:30:00 |
|
| 2025-02-25 16:15:00 |
|
| 2025-02-24 07:48:00 |
|
| 2025-02-20 16:45:00 |
|
| 2025-02-20 16:15:00 |
|
| 2025-01-29 06:00:00 |
|
| 2025-01-21 07:26:00 |
|
| 2025-01-15 08:30:00 |
|
📰 Browse additional press releases for Danaher!
Sign up for free or log in🆓 Discover "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free eBook!